Jianning Jiang

737 total citations
27 papers, 170 citations indexed

About

Jianning Jiang is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Jianning Jiang has authored 27 papers receiving a total of 170 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 13 papers in Hepatology and 3 papers in Surgery. Recurrent topics in Jianning Jiang's work include Liver Disease Diagnosis and Treatment (12 papers), Hepatitis C virus research (11 papers) and Hepatitis B Virus Studies (10 papers). Jianning Jiang is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Hepatitis C virus research (11 papers) and Hepatitis B Virus Studies (10 papers). Jianning Jiang collaborates with scholars based in China, United States and Germany. Jianning Jiang's co-authors include Minghua Su, Jia Shang, Rongming Wang, Qing Xie, Hong Chen, Zhiliang Gao, Jun Li, Fengmin Lu, Rui Huang and Fanglin Wei and has published in prestigious journals such as Scientific Reports, Journal of Affective Disorders and Frontiers in Oncology.

In The Last Decade

Jianning Jiang

24 papers receiving 167 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianning Jiang China 7 123 94 33 12 12 27 170
Sebastian Wallace United Kingdom 4 82 0.7× 114 1.2× 34 1.0× 23 1.9× 17 1.4× 6 153
Jennifer Leong United States 8 123 1.0× 91 1.0× 48 1.5× 17 1.4× 9 0.8× 15 195
Milotka Fabri Serbia 6 165 1.3× 163 1.7× 48 1.5× 9 0.8× 15 1.3× 27 223
Dana Busschots Belgium 8 226 1.8× 152 1.6× 30 0.9× 19 1.6× 26 2.2× 20 280
Ahmed F. Sherief Egypt 7 167 1.4× 165 1.8× 54 1.6× 15 1.3× 11 0.9× 20 246
MY Maïga Mali 3 259 2.1× 241 2.6× 26 0.8× 19 1.6× 9 0.8× 7 308
Mohsen Salama Egypt 7 112 0.9× 101 1.1× 22 0.7× 8 0.7× 4 0.3× 23 180
Shunsaku Kaji Japan 7 97 0.8× 96 1.0× 21 0.6× 43 3.6× 25 2.1× 11 227
Tatjana Reić Spain 5 161 1.3× 114 1.2× 14 0.4× 16 1.3× 6 0.5× 9 176
Dragan Delić Serbia 11 274 2.2× 257 2.7× 39 1.2× 11 0.9× 13 1.1× 46 351

Countries citing papers authored by Jianning Jiang

Since Specialization
Citations

This map shows the geographic impact of Jianning Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianning Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianning Jiang more than expected).

Fields of papers citing papers by Jianning Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianning Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianning Jiang. The network helps show where Jianning Jiang may publish in the future.

Co-authorship network of co-authors of Jianning Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Jianning Jiang. A scholar is included among the top collaborators of Jianning Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianning Jiang. Jianning Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Qingxia, et al.. (2025). Association between mixed exposure of phenols, parabens, phthalates and cognitive function in US elders. Journal of Affective Disorders. 382. 139–147. 1 indexed citations
2.
Li, Qingmei, et al.. (2025). Evaluation of serum ESPL1 as a biomarker for early diagnosis of HBV-related hepatocellular carcinoma. Frontiers in Oncology. 15. 1574317–1574317.
3.
4.
Wang, Rongming, et al.. (2024). Impact of HBV Integration on Hepatocellular Carcinoma After Long-Term Antiviral Therapy. International Journal of General Medicine. Volume 17. 2643–2653. 2 indexed citations
5.
6.
Liu, Mei, Tao Jiang, Qinghua Yu, et al.. (2023). HIV-1 RNA and DNA Genotyping Drug Resistance Detection in Patients with Low-Level Viremia in Liangshan, China. AIDS Research and Human Retroviruses. 39(8). 429–435. 4 indexed citations
7.
Yang, Lu, Shuang Ren, & Jianning Jiang. (2023). Development and validation of a nomogram for survival prediction in hepatocellular carcinoma after partial hepatectomy. BMC Surgery. 23(1). 27–27. 2 indexed citations
8.
Li, Xiaoting, et al.. (2023). A Retrospective Study of Long-Term Clinical Outcomes in Patients with Chronic Hepatitis C Treated with Interferon and Ribavirin. Discovery Medicine. 35(178). 868–868. 1 indexed citations
9.
10.
11.
Jiang, Jianning, Y Zhang, Shenwen Cai, et al.. (2023). [Research on the association between unhealthy lifestyle and psychological distress among Chinese children and adolescents aged 9-18 years].. PubMed. 44(10). 1567–1574. 3 indexed citations
12.
13.
14.
Li, Tiantian, et al.. (2021). Voriconazole Versus Amphotericin B as Induction Therapy for Talaromycosis in HIV/AIDS Patients: A Retrospective Study. Mycopathologia. 186(2). 269–276. 20 indexed citations
15.
Wang, Rongming, et al.. (2020). Serum ESPL1 Can Be Used as a Biomarker for Patients With Hepatitis B Virus-Related Liver Cancer: A Chinese Case-Control Study. Technology in Cancer Research & Treatment. 19. 1079248433–1079248433. 7 indexed citations
16.
Jiang, Jianning, et al.. (2020). [Liver histological status and clinic outcome in HBeAg-negative chronic hepatitis B with low viral load].. PubMed. 28(12). 1013–1017. 2 indexed citations
17.
Huang, Wen, Rongming Wang, Minghua Su, et al.. (2019). High Rate of Detection of Human ESPL1-HBV S Fusion Gene in Patients With HBV-related Liver Cancer: A Chinese Case–Control Study. Anticancer Research. 40(1). 245–252. 12 indexed citations
18.
Huang, Rui, Huiying Rao, Jia Shang, et al.. (2018). A cross-sectional assessment of health-related quality of life in Chinese patients with chronic hepatitis c virus infection with EQ-5D. Health and Quality of Life Outcomes. 16(1). 124–124. 32 indexed citations
19.
Wang, Rongming, Jiaxin Fu, Minghua Su, et al.. (2017). Integration of hepatitis B virus S gene impacts on hepatitis B surface antigen levels in patients with antiviral therapy. Journal of Gastroenterology and Hepatology. 33(7). 1389–1396. 30 indexed citations
20.
Rao, Huiying, Lai Wei, Hong Li, et al.. (2015). Prevalence of abnormal glycometabolism in treatment‐naive patients with hepatitis C virus infection in a C hinese H an population. Journal of Gastroenterology and Hepatology. 30(6). 1049–1056. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sebastian Wallace Breakdown of academic impact, for papers by Jennifer Leong Breakdown of academic impact, for papers by Milotka Fabri Breakdown of academic impact, for papers by Dana Busschots Breakdown of academic impact, for papers by Ahmed F. Sherief Breakdown of academic impact, for papers by MY Maïga Breakdown of academic impact, for papers by Mohsen Salama Breakdown of academic impact, for papers by Shunsaku Kaji Breakdown of academic impact, for papers by Tatjana Reić Breakdown of academic impact, for papers by Dragan Delić
Rankless by CCL
2026